SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?


To: Hank who wrote (4772)10/25/2003 2:39:28 AM
From: StockDung  Respond to of 5582
 
STRONG SPECULATIVE BUY!!->"CURE FOR COMMON COLD PATENTED"

From: George A. Eby III (73700.2627@CompuServe.COM)
Subject: CURE FOR COMMON COLD PATENTED
View: Complete Thread (4 articles)
Original Format
Newsgroups: bionet.virology, sci.chem.organomet, sci.med.pharmacy, alt.inventors
Date: 1995/06/11


The CURE FOR COMMON COLD has been patented.

See U.S. Patent number 5,409,905 issued April 25, 1995.
Inventor: George A. Eby III, Austin, Texas Compuserve ID
#73750,2164
Published technical information sources available
include: (a) Peer reviewed journal of Pharmacy Technology article
entitled "Dose-Response Linearity in Dose Response from Zinc
Lozenges in Treatment of Common Colds" published June 9, 1995, by
Harvey Whitney Book Company, Cincinati, Ohio. (b) book article
entitled "The Zinc Lozenge and Common Cold Story" in Metal-
Ligand Interactions in Biological Fluids: Bioinorganic Medicine,
volume 2, pages 1182-1190, edited by Guy Berthon PhD, Research
Director INSERM Unit 305, Toulouse, France, published in June of
1995 by Marcel Dekker, Inc. of New York, and (c) Handbook for
Curing the Common Cold - The Zinc Lozenge Story (ISBN
0-9638967-0-9) published by George Eby Research, Austin, Texas.

Although product development is essentially complete, until a US
FDA New Drug Application is approved, these patented COLD CURE
throat lozenges are available only to pharmacists and physicians,
and medical and pharmacology researchers at government, corporate
and private research centers.

--
George A. Eby III



To: Hank who wrote (4772)10/25/2003 2:44:08 AM
From: StockDung  Respond to of 5582
 
From: George A. Eby III (73700.2627@CompuServe.COM)
Subject: Effect of Zn2+ in common colds
This is the only article in this thread
View: Original Format
Newsgroups: bionet.virology, sci.chem.organomet, sci.med, sci.med.immunology, sci.med.pharmacy
Date: 1996/01/30


We have all been taught over and over again that there is no such
thing as a cure for the common cold. Right? Some years ago, the
U.S. government announced that there was no possibility of a
vaccine that would prevent colds, because there were too many
viruses that cause common colds. Unfortunately that true
statement was generally misinterpreted as, "There is no cure for
the common cold". I would like to clarify the record as one has
been found and patented in 1995. For more information see the
following resource:
>>HANDBOOK FOR CURING THE COMMON COLD - THE ZINC LOZENGE STORY (ISBN 0-9638967-0-9).
>>"Linearity in Dose-Response from Zinc Lozenges in the Treatment
of Common Colds", JOURNAL OF PHARMACY TECHNOLOGY, V11 #3
pp110-122.
>>"The Zinc Lozenge and Common Cold Story" in the
state-of-the-art (Editor Guy Berthon, PhD, INSERM Unit
305,Toulouse, France) METAL-LIGAND INTERACTIONS IN BIOLOGICAL
FLUIDS: BIOINORGANIC MEDICINE v2 pp 1182-1190, Marcel Dekker
Inc., NY, NY, 1995.
>>See our URL at:
ourworld.compuserve.com

--
George A. Eby III



To: Hank who wrote (4772)10/25/2003 2:52:49 AM
From: StockDung  Respond to of 5582
 
From: George Eby (coldcure@realtime.com)
Subject: Navicular Disease- curable!
View: Complete Thread (2 articles)
Original Format
Newsgroups: rec.equestrian
Date: 1996/09/29


Is Navicular Disease in Horses Curable? Probably!

by George Eby, 2109 Paramount Avenue Austin, Texas 78704
e-mail coldcure@coldcure.com voice/fax 442-2933

Is navicular disease curable? From a historical perspective, it is
not. Steel egg bar shoes, more upright shoeing, and isoxoprine are the
best bets in the early stages, with nerving performed in the later
stages. Eventually, the horse becomes no longer usable, remains a
cripple for the rest of its life, or is euthanized. The navicular bone
of a horse acts as a fulcrum over which tendons from the back of the leg
attach to the coffin bone in the foot. This fulcrum is subject to both
compressive and surface shear forces. That navicular disease in horses
starts as result of a trauma, over exertion, malnutrition and
combinations is well accepted.
However, positively charged, trivalent aluminum ions (Al3+) is one
important previously unrecognized cause of bone resorption and
osteomalacia (bone softening, crushing, and breaking in mature
vertebrates not associated with Vitamin D deficiency), and in particular
the loss of surface bone. Aluminum ions in bone cause bone pain and
proximal myopathy (disorders of adjoining muscles).(ref 1)
The similarities in surface bone loss caused by aluminum ion compared
to surface bone loss in navicular disease sound strikingly similar.
Aluminum is the third most abundant element on the surface of the
Earth. It has been held captive in rock biologically unavailable for 3
billion years. Industrialization has resulted in acid rains that have
decreased the pH of lake waters to the point where Al3+ is leached out
of rocks and soil. Horses can also pick up biologically available
aluminum from plants and grasses. In the case of horses with aluminum
shoes, acidification from urine could leach out Al3+ from the shoe and
be directly absorbed into the feet. Aluminum ion has no role in
vertebrate life-forms, and is always considered a toxin.
Aluminum is a group IIIa element under boron in the periodic table of
the elements. In some complex boron-containing biomolecules, boron
prevents bone resorption in laboratory animals, exactly the reverse of
aluminum, however it has some neurotoxicity.
Below aluminum in the periodic table is gallium, a liquid metal at room
temperature. Gallium, in considerable excess of aluminum, effectively
competes with aluminum for absorption in bone and displaces aluminum,
similar to the way that immunoregulatory zinc replaces carcinogenic
cadmium found in tobacco smoke.
According to Raymond P. Warrell, Jr., M.D., of the Memorial Sloan
Kettering Cancer Center, in New York City, elemental gallium and its
various compounds are potent inhibitors of bone resorption that acts to
maintain or restore bone mass. By virtue of these biological effects,
gallium compounds (mainly gallium nitrate) are useful treatments for a
variety of human diseases that are characterized by accelerated bone
loss, including cancer-related hypercalcemia, bone metastases, Paget's
disease, and post menopausal osteoporosis.(REF 2)
Gallium nitrate in appropriate dosages is considered a safe and highly
effective agent in reducing accelerated bone loss in both cancer and
metabolic bone disease, and in restoration of bone mass. Gallium
nitrate converts blood hypercalcemia into hypocalcemia, resulting in a
marked reduction in urinary calcium. It causes a higher accretion rate
of radio-labeled calcium into bone, suggesting gallium nitrate enhanced
mineralization of newly forming bone rather than simply acting to
decrease physiologic resorption. Gallium concentrates in the
metabolically active metaphysis (end), and notably in the epiphyseal
region of bones along with calcium strengthening bone.(REF 2)
Dr. Warrell suggested to me by telephone in August, 1996, that a
navicular horse would reasonably benefit from a 250 mg oral dose of
gallium nitrate per day as an adjunct to standard treatments and reduced
work. He could not predict a time period for recovery. Consequently,
an X-ray exam should be performed at the start of treatment, days 30,
60, 120, 180 and 365 until the literature establishes the average
recovery time. Bone pain (lameness) will disappear much sooner than
complete bone repair, consequently, training and exertion should be
limited until X-ray examination shows recovery is complete.
Gallium nitrate by the Aldridge Corporation is available in reagent
grade (99.99% pure) from many chemical supply houses in bulk form.
It would seem that aluminum shoes could be a contributing factor to
navicular disease and their non-use should be considered. Switching to
steel egg bar shoes also could be beneficial by eliminating a possible
source of Al3+ ion.
_______________________
(1) Alfrey Allen C., M.D. (1995) "Toxicity of Detrimental Metal Ions -
Aluminum", (Guy Berthon, editor), Handbook of Metal-Ligand
Interactions in Biological Fluids - Bioinorganic Medicine, Volume 2,
Marcel
Dekker, Inc., New York.

(2) Warrell, Raymond P., M.D., "Gallium for Treatment of Bone Diseases",
ibid.
--
GEORGE EBY RESEARCH
2109 Paramount Avenue, Austin, TX 78704 US
voice/fax 512-442-2933
coldcure.com e-mail coldcure@coldcure.com



To: Hank who wrote (4772)10/25/2003 2:58:58 AM
From: StockDung  Respond to of 5582
 
wow, a cure for the common cold web.archive.org